NO20074528L - Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme - Google Patents

Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme

Info

Publication number
NO20074528L
NO20074528L NO20074528A NO20074528A NO20074528L NO 20074528 L NO20074528 L NO 20074528L NO 20074528 A NO20074528 A NO 20074528A NO 20074528 A NO20074528 A NO 20074528A NO 20074528 L NO20074528 L NO 20074528L
Authority
NO
Norway
Prior art keywords
same
preparation
compositions
processes
substituted pyrroles
Prior art date
Application number
NO20074528A
Other languages
English (en)
Norwegian (no)
Inventor
Baptiste Ronan
Michel Tabart
Fabrice Viviani
Eric Bacque
Catherine Souaille
Pascal Desmazeau
Jean-Philippe Lettalec
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35478244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074528(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20074528L publication Critical patent/NO20074528L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20074528A 2005-02-10 2007-09-06 Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme NO20074528L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501354A FR2881742B1 (fr) 2005-02-10 2005-02-10 Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2006/000286 WO2006084996A1 (fr) 2005-02-10 2006-02-08 Pyrroles substitues compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
NO20074528L true NO20074528L (no) 2007-10-31

Family

ID=35478244

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074528A NO20074528L (no) 2005-02-10 2007-09-06 Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme

Country Status (36)

Country Link
US (1) US7592365B2 (da)
EP (1) EP1851198B1 (da)
JP (1) JP2008530061A (da)
KR (1) KR20070101317A (da)
CN (1) CN101115716A (da)
AR (1) AR052571A1 (da)
AT (1) ATE419234T1 (da)
AU (1) AU2006212106A1 (da)
BR (1) BRPI0606955A2 (da)
CA (1) CA2596822A1 (da)
CR (1) CR9231A (da)
CY (1) CY1108916T1 (da)
DE (1) DE602006004566D1 (da)
DK (1) DK1851198T3 (da)
DO (1) DOP2006000028A (da)
EA (1) EA013060B1 (da)
ES (1) ES2319926T3 (da)
FR (1) FR2881742B1 (da)
GT (1) GT200600048A (da)
HR (1) HRP20090158T1 (da)
IL (1) IL184488A0 (da)
MA (1) MA29248B1 (da)
MX (1) MX2007008789A (da)
MY (1) MY142082A (da)
NO (1) NO20074528L (da)
PA (1) PA8661601A1 (da)
PE (1) PE20061086A1 (da)
PL (1) PL1851198T3 (da)
PT (1) PT1851198E (da)
RS (1) RS50806B (da)
SI (1) SI1851198T1 (da)
TN (1) TNSN07241A1 (da)
TW (1) TW200640858A (da)
UY (1) UY29371A1 (da)
WO (1) WO2006084996A1 (da)
ZA (1) ZA200706157B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation
MX2009004371A (es) * 2006-10-23 2009-06-11 Lexicon Pharmaceuticals Inc Proceso para la preparacion de 5-alquil-7h-pirrolo[2,3-d]piri-midi n-2-oles.
TW201111385A (en) 2009-08-27 2011-04-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors
US20120244141A1 (en) 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
WO2020034988A1 (zh) * 2018-08-14 2020-02-20 江苏豪森药业集团有限公司 凋亡信号调节激酶1抑制剂的盐及其晶型
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107901D0 (en) * 2001-03-29 2001-05-23 Cyclacel Ltd Anti-cancer compounds
DE60228295D1 (de) * 2001-09-21 2008-09-25 Smithkline Beecham Corp Chemische verbindungen
JP2006515828A (ja) 2001-09-27 2006-06-08 スミスクライン・ビーチャム・コーポレイション 化学化合物
US20040138269A1 (en) * 2002-10-11 2004-07-15 Sugen, Inc. Substituted pyrroles as kinase inhibitors
GB0229581D0 (en) * 2002-12-19 2003-01-22 Cyclacel Ltd Use
WO2004083203A1 (en) * 2003-03-13 2004-09-30 Vertex Pharmaceuticals Incorporated Compositions useful as protein kinase inhibitors
DE10354060A1 (de) * 2003-11-19 2005-06-02 Merck Patent Gmbh Pyrrolderivate
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation

Also Published As

Publication number Publication date
DE602006004566D1 (de) 2009-02-12
ZA200706157B (en) 2008-11-26
EA200701688A1 (ru) 2007-12-28
MY142082A (en) 2010-08-30
ES2319926T3 (es) 2009-05-14
UY29371A1 (es) 2006-10-02
DK1851198T3 (da) 2009-05-04
US20080167368A1 (en) 2008-07-10
KR20070101317A (ko) 2007-10-16
MA29248B1 (fr) 2008-02-01
DOP2006000028A (es) 2006-09-15
EA013060B1 (ru) 2010-02-26
CY1108916T1 (el) 2014-07-02
TNSN07241A1 (en) 2008-11-21
CA2596822A1 (fr) 2006-08-17
PT1851198E (pt) 2009-03-26
CN101115716A (zh) 2008-01-30
EP1851198A1 (fr) 2007-11-07
EP1851198B1 (fr) 2008-12-31
AR052571A1 (es) 2007-03-21
BRPI0606955A2 (pt) 2009-07-28
TW200640858A (en) 2006-12-01
ATE419234T1 (de) 2009-01-15
US7592365B2 (en) 2009-09-22
MX2007008789A (es) 2007-09-11
HRP20090158T1 (en) 2009-05-31
AU2006212106A1 (en) 2006-08-17
IL184488A0 (en) 2007-10-31
PL1851198T3 (pl) 2009-06-30
CR9231A (es) 2007-10-23
SI1851198T1 (sl) 2009-06-30
GT200600048A (es) 2006-07-03
FR2881742A1 (fr) 2006-08-11
WO2006084996A1 (fr) 2006-08-17
RS50806B (sr) 2010-08-31
PE20061086A1 (es) 2006-11-30
JP2008530061A (ja) 2008-08-07
FR2881742B1 (fr) 2007-09-07
PA8661601A1 (es) 2006-09-08

Similar Documents

Publication Publication Date Title
TW200639173A (en) Substituted pyrazolopyridines, compositions containing same, manufacturing process therefor and use thereof
TW200738659A (en) Novel compounds
EA200702329A1 (ru) Замещенные пирролпиридины, содержащие их композиции, способ получения и применение
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
TW200800999A (en) Novel compounds
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
UA103319C2 (en) Thiazole- and oxazole-benzene sulfonamide compounds
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
NO20090295L (no) Substituerte heteroarylderivater
TW200801003A (en) Novel compounds
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
TW200745084A (en) Novel compounds
GB0508314D0 (en) Organic compounds
EA200701648A1 (ru) Замещённые пирролы и имидазолы, содержащие их композиции, способ получения и применение
TW200745122A (en) New compounds I
SE0401762D0 (sv) Novel compounds
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
DE602004024213D1 (en) Aminopropanolderivate
NO20091990L (no) Substituerte pyrazoler, sammensetninger inneholdende disse, fremgangsmate for fremstilling og anvendelse
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
SE0300457D0 (sv) Novel compounds
GB0615105D0 (en) Novel compounds
NO20091386L (no) Fenyloksyanilinderivater
WO2006090265A3 (en) Processes for the preparation of levetiracetam, its intermediate and the use of levetiracetam in pharmaceutical compositions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application